Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000019

Director sold 1,377 shares at $30.88 ($42,522)

From the SEC's structured data for this filing

Trades in this filing

Krognes Steve E. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-02-08 Sale : show line 1 in the form −1,377 $30.88 $42,522 145,121 D
Open-market sales · 1,377 sh · avg $30.88 · $42,522
Loading xslF345X03/wf-form4_167607058932396.xml…